PYC Therapeutics Limited (ASX: PYC)

PYC Therapeutics Revenue

In the fiscal year ending June 30, 2024, PYC Therapeutics had annual revenue of 22.06M AUD with 39.56% growth. PYC Therapeutics had revenue of 13.15M in the half year ending June 30, 2024, with 30.89% growth.

• Revenue: 22.06M
• Revenue Growth: +39.56%
• P/S Ratio: 25.87
• Revenue / Employee: 4.41M
• Employees: 5
• Market Cap: 676.58M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	22.06M	6.25M	39.56%
Jun 30, 2023	15.81M	-236.57K	-1.47%
Jun 30, 2022	16.04M	12.97M	421.83%
Jun 30, 2021	3.07M	678.66K	28.33%
Jun 30, 2020	2.40M	-	-